Navigation Links
Medtronic Announces Positive Nine-Month Results for Endeavor,Resolute Next Generation Drug-Eluting Stent at EuroPCR

inical trial will be used to support the CE Mark application.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.

Caution: The Endeavor Drug-Eluting Coronary Stent is an investigational device with an investigational drug (Zotarolimus) and exclusively for clinical investigation in the United States.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K for the year ended April 28, 2006. Actual results may differ materially from anticipated results.

Contact

Medtronic, Inc.
Public Relations:
Yvan Deurbroeck, 41 79 249 3670
or
Scott Papillon, 707-591-7367
or
Investor Relations:
Jeff Warren, 763-505-2696


'"/>




Page: 1 2 3

Related medicine technology :

1. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
2. Study Supports Cost-Effectiveness of Medtronics Spasticity Treatment for Children with Cerebral Palsy
3. Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stents Positive Clinical Profile
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease

Post Your Comments:
(Date:11/30/2009)...S, Nov. 30 Nonin Medical, Inc., a ...tions and the inventor of fingertip pulse oximetry...ican Product Line Strategy Award in Remote Patient...rate remote physiological monitoring, Nonin Medica... provider of telemedicine monitoring equipment. ,...
(Date:11/30/2009)... Calif., Nov. 30 Nektar ...promotion of Lorianne Masuoka, M.D. to Senior Vice... will report directly to Nektar,s President and Ch...orianne,s outstanding leadership and highly effect...rumental in rapidly advancing Nektar,s proprietary...
(Date:11/30/2009)....J., Nov. 30 Covance Inc...ent at the Piper Jaffray 21st Annual Health Care C....m. (ET). Investors may access a live webcast of ...o register and download any necessary software, pl...headquarters in Princeton, New Jersey, is one of t...
Breaking Medicine Technology:Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 2Nonin Medical is Recognized by Frost & Sullivan for Remote Patient Monitoring Leadership 3Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3New species of phallus shaped mushroom named after California Academy of Sciences scientist 8844 1New species of phallus shaped mushroom named after California Academy of Sciences scientist 8844 2Hudson Institute Debates the Long Term Fiscal Impact of Health Care Reform 48949 1Hudson Institute Debates the Long Term Fiscal Impact of Health Care Reform 48949 2American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO HOSPIRIO in Cuenca Ecuador 48945 1American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO HOSPIRIO in Cuenca Ecuador 48945 2
...dy results presented at the Scoliosis Research Soc... Lake City, SALT LAKE CITY, Sept. 11 Researchers...have identified specific genetic markers,for scoli... for the,development of a DNA-based prognostic tes...olescent Idiopathic Scoliosis., This groundbreaki...
...KVILLE, Md., Sept. 11 Vanda,Pharmaceuticals Inc. ...sed on,the development and commercialization of cl...s system disorders, reported today that it met wit...operidone non-approvable action,letter that the co... arguments to support its belief that iloperidone,...
Other Medicine Technology:Researchers at Axial Biotech Develop a DNA Test for Scoliosis 2Vanda Pharmaceuticals Provides Update on Iloperidone 2Vanda Pharmaceuticals Provides Update on Iloperidone 3
(Date:12/1/2009)... , , SAN DIEGO, Dec. 1 /PRNewswire-Fi...ied supplier of Farming, Nursery and Wellness prod...ing agreement with Southern California Micro-Lendi...m ). ,, Yan Skwara, CEO of US Farms, Inc. stat... partnership with Angels in Action utilizing our A...
(Date:12/1/2009)... , , BRUSSELS, December 1 /PRNewswir...perts Agree That Adapting Food,Production and Mode...ons , Prof. John Beddington, Chief Scient...ll agricultural policy must be founded on science ...cientific advisor with the,responsibility to look ...
(Date:12/1/2009)... Some become so worried about what might happen t..., , TUESDAY, Dec. 1 (HealthDay News) -- ...into depression, a new study suggests. , "Anxie...udy author Andres Viana, a graduate student in psy...ose with anxiety sensitivity are afraid of their a...
(Date:12/1/2009)... Radiation exposures in younger women may up chan... Dec. 1 (HealthDay News) -- Mammograms may actuall...k women, a new study suggests. , Dutch research...r examining the effect of low-dose radiation expos...mutation boosting breast cancer risk and two looki...
(Date:12/1/2009)... , Research released in the December 2009 issue o...ermine whether the survival improvement among pati... the last two decades as reported in controlled cl...sis of over 100,000 patients with stage IV non-sma... SEER database to evaluate trends in survival betw...
Breaking Medicine News(10 mins):Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 3Health News:Food Security to be the Top Issue for EU's Science Chief 2Health News:Fear of Anxiety May Lead to Depression 2Health News:Mammograms May Boost Cancer Risk in High-Risk Women 2
... increase your chance of having colorectal cancer/... Cancer Institute. Colon and rectum together ...cancer is also called colorectal cancer. Cancer of...tive Investigation into Cancer and Nutrition have ...
...patients with the help of seroquel is effective//,... severe disabling mental illness. Some of the symp...seen or heard, feelings of being persecuted, becom...ough most schizophrenic patients are not aggressiv...
... why the diabetes drug thiazolidinediones (TZDs) c...ity of Utah had found that the drug TZDs activates...or-activated receptor gamma (PPAR). This is situat...nerally used to lower blood sugar levels and lipid...
...tions of the gum may increase the risk of the Alzh...rly in life. According to a research study th...on International Conference on Prevention of Demen...nd slowly destroys them. The main symptoms of the ...
...p that can keep people have a long life//. An...he benefits of having friends do affect the health...t life expectancy can get significantly increased.... 70 years and above. Researchers had monitored fac...
...ranelate to be used for treating patients with ost...escribing the drug it is important to observe the ...in the British Medical Journal has said that the d...recent studies on the drug had shown the drug to b...
Other Medicine News:
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
...onal reference laboratory and a worldwide leader i...ARUP offers an extensive test menu of highly compl...ic pathology. Owned by the University of Utah, ARU...the nation's university teaching hospitals and chi...
Medicine Products: